MedTrace Logo

TRANEXAMIC ACID IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY IN A BRAZILIAN REFERENCE ORTHOPEDIC CENTER: A RANDOMIZED CONTROLLED TRIAL

NCT03019198 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2017-03-09

No results posted yet for this study

Summary

This study aims to analyze the efficacy of intravenous tranexamic acid (TXA) in patients undergoing total hip arthroplasty (THA).

Conditions

  • Blood Loss, Surgical
  • Tranexamic Acid Adverse Reaction
  • Hip Replacement

Interventions

DRUG

Tranexamic Acid Injectable Solution

Intravenous 15 mg per kilogram tranexamic acid

DRUG

Placebo - Concentrate

Sponsors & Collaborators

  • Instituto Nacional de Traumatologia e Ortopedia

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-03-31
Completion
2016-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03019198 on ClinicalTrials.gov